HUMDF (Hua Medicine) Other Gross PPE : $13.97 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Other Gross PPE?

Hua Medicine's Other Gross PPE for the quarter that ended in Jun. 2024 was $13.97 Mil.

Hua Medicine's quarterly Other Gross PPE declined from Jun. 2023 ($17.80 Mil) to Dec. 2023 ($-5.25 Mil) but then increased from Dec. 2023 ($-5.25 Mil) to Jun. 2024 ($13.97 Mil).

Hua Medicine's annual Other Gross PPE increased from Dec. 2021 ($0.97 Mil) to Dec. 2022 ($1.09 Mil) but then declined from Dec. 2022 ($1.09 Mil) to Dec. 2023 ($-5.25 Mil).

Hua Medicine Other Gross PPE Historical Data

The historical data trend for Hua Medicine's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine Other Gross PPE Chart

Hua Medicine Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

0.56

0.92

0.97

1.09

-5.25

Hua Medicine Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Gross PPE	Get a 7-Day Free Trial											22.59	1.09	17.80	-5.25	13.97

Hua Medicine Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Hua Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » Other Gross PPE

Traded in Other Exchanges

02552:Hong Kong

Address

Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203

Website

https://www.huamedicine.com

Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.